By Caitlin Kelly
Here’s how to find one, my story yesterday from Forbes.
The backstory, for those of you who don’t use or need one, is the staggering price increase for the EpiPen, an injectable device that pumps epinephrine into your system to address anaphylactic shock, an allergic reaction to nuts, shellfish, fish or any number of substances.
If someone goes into that shock, they need the injection within 30 minutes or they can die.
In the U.S. — whose entire healthcare “system” is run to wring the maximum profit from our inevitable physical needs — there’s only one company making them right now, Mylan, whose female CEO, Heather Bresch, the daughter of a Senator, no less, might be the most loathed individual in the country right now.
Knowing she has the market cornered, (as other competitors left the field), she spiked the price of EpiPens to $600 — a huge jump, and one that makes a lifesaving device unaffordable to many people.
(The company, now under tremendous public fire, is offering a $300 coupon.)
Imagine needing, (as some people do), three sets for each child: school, home and your vehicle, a cool $1,800 to start.
Oh, and Bresch earns $19 million for her.…ethics.
I’ve been following this story, not because anyone I know uses an EpiPen but because I’m so sickened by corporate greed.
I also grew up, to the age of 30, in a nation with strict government oversight and regulation of drugs, medications and device prices — so no one gets gouged.
I decided to pursue this story on Friday morning, and started at 10:00 a.m.
I put out calls and urgent emails to sources in the U.S. and Canada, racing the clock to get the story reported and written quickly; as a “trending topic”, I needed to get it posted as soon as I could, yet make sure I was producing a smart, well-written and well-sourced piece.
Social media saved my bacon — a request to a writers’ group I belong to on Facebook prompted a fast reply from someone who knew a physicians (!) who personally relies on EpiPens and who emailed me back quickly and in detail.
Working behind the scenes with my editor who, as usual and of course, I haven’t met, we discussed how to best present the story, an angle I hadn’t read anywhere else — yet.
We posted the finished story, about 1,200 words, by 5pm. (Good thing I’ve worked as a daily newspaper reporter. That kind of speed is normal for me.)